Total Payments
$2,717
2024 Payments
$150.61
Companies
39
Transactions
104
Medicare Patients
1,576
Medicare Billing
$263,041
Payment Breakdown by Category
Food & Beverage$2,377 (87.5%)
Education$340.02 (12.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,377 | 97 | 87.5% |
| Education | $340.02 | 7 | 12.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $286.71 | 13 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $215.26 | 12 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $206.93 | 5 | $0 (2018) |
| Pharmacyclics LLC, An AbbVie Company | $199.14 | 7 | $0 (2021) |
| Janssen Biotech, Inc. | $153.61 | 7 | $0 (2024) |
| GlaxoSmithKline, LLC. | $123.43 | 1 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $111.82 | 3 | $0 (2018) |
| Haemonetics Corporation | $108.04 | 1 | $0 (2021) |
| Celgene Corporation | $105.88 | 6 | $0 (2018) |
| SANOFI-AVENTIS U.S. LLC | $99.00 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $150.61 | 6 | Novartis Pharmaceuticals Corporation ($33.06) |
| 2023 | $109.94 | 5 | ABBVIE INC. ($34.94) |
| 2022 | $93.43 | 5 | Karyopharm Therapeutics Inc. ($23.80) |
| 2021 | $478.47 | 12 | GlaxoSmithKline, LLC. ($123.43) |
| 2020 | $110.48 | 4 | Amgen Inc. ($75.43) |
| 2019 | $59.16 | 1 | Janssen Scientific Affairs, LLC ($59.16) |
| 2018 | $755.08 | 32 | E.R. Squibb & Sons, L.L.C. ($123.24) |
| 2017 | $960.07 | 39 | Pharmacyclics LLC, An AbbVie Company ($126.60) |
All Payment Transactions
104 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/23/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $22.74 | General |
| Category: ONCOLOGY | ||||||
| 06/24/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ICLUSIG (Drug) | Food and Beverage | In-kind items and services | $30.31 | General |
| Category: ONCOLOGY | ||||||
| 05/15/2024 | PFIZER INC. | IBRANCE (Drug), TUKYSA | Food and Beverage | In-kind items and services | $24.19 | General |
| Category: ONCOLOGY | ||||||
| 04/11/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), IMBRUVICA, TALVEY | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: Oncology | ||||||
| 02/29/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $33.06 | General |
| Category: Oncology | ||||||
| 02/07/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $21.11 | General |
| Category: Iron Deficiency Anemia | ||||||
| 09/28/2023 | Amgen Inc. | LUMAKRAS (Drug) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: Oncology | ||||||
| 06/29/2023 | SOBI, INC | Doptelet (Drug) | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 06/22/2023 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $34.94 | General |
| Category: ONCOLOGY | ||||||
| 02/23/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LENVIMA | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: ONCOLOGY | ||||||
| 02/16/2023 | Novartis Pharmaceuticals Corporation | KISQALI (Drug), PIQRAY | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: Oncology | ||||||
| 10/06/2022 | Amgen Inc. | LUMAKRAS (Drug) | Food and Beverage | In-kind items and services | $22.25 | General |
| Category: Oncology | ||||||
| 08/10/2022 | Karyopharm Therapeutics Inc. | XPOVIO (Drug) | Education | In-kind items and services | $23.80 | General |
| Category: Oncology | ||||||
| 07/13/2022 | Lilly USA, LLC | CYRAMZA (Drug), VERZENIO, RETEVMO | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: Oncology | ||||||
| 05/05/2022 | Novartis Pharmaceuticals Corporation | KISQALI (Drug), FEMARA | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: ONCOLOGY | ||||||
| 04/21/2022 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: Oncology / Rare Diseases | ||||||
| 12/02/2021 | GlaxoSmithKline, LLC. | BLENREP (Biological) | Food and Beverage | In-kind items and services | $123.43 | General |
| Category: ONCOLOGY | ||||||
| 09/24/2021 | Pharmacyclics LLC, An AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $23.05 | General |
| Category: ONCOLOGY | ||||||
| 09/02/2021 | Pharmacyclics LLC, An AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: ONCOLOGY | ||||||
| 07/29/2021 | Amgen Inc. | LUMAKRAS (Drug) | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: Oncology | ||||||
| 06/15/2021 | Haemonetics Corporation | TEG6s HEMOSTASIS SYSTEM (Device) | Food and Beverage | In-kind items and services | $108.04 | General |
| Category: Devices | ||||||
| 06/10/2021 | Novartis Pharmaceuticals Corporation | PROMACTA (Drug), RYDAPT | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: ONCOLOGY | ||||||
| 05/27/2021 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $25.79 | General |
| Category: ONCOLOGY | ||||||
| 04/21/2021 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $20.47 | General |
| Category: Oncology | ||||||
| 03/18/2021 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $21.90 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 320 | 648 | $120,544 | $58,455 |
| 2022 | 4 | 367 | 711 | $121,395 | $63,791 |
| 2021 | 4 | 433 | 891 | $147,005 | $82,208 |
| 2020 | 4 | 456 | 806 | $126,486 | $58,587 |
Total Patients
1,576
Total Services
3,056
Medicare Billing
$263,041
Procedure Codes
16
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 88 | 347 | $71,361 | $37,097 | 52.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 121 | 181 | $28,270 | $12,386 | 43.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 41 | 41 | $12,996 | $5,444 | 41.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 70 | 79 | $7,917 | $3,528 | 44.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 97 | 338 | $65,738 | $36,808 | 56.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 149 | 242 | $34,890 | $17,081 | 49.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 42 | 42 | $12,294 | $5,831 | 47.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 79 | 89 | $8,473 | $4,071 | 48.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 118 | 444 | $82,894 | $48,885 | 59.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 179 | 297 | $40,781 | $21,598 | 53.0% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 51 | 51 | $14,217 | $7,084 | 49.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 85 | 99 | $9,113 | $4,642 | 50.9% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 127 | 367 | $63,737 | $31,099 | 48.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 167 | 262 | $34,768 | $14,778 | 42.5% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 70 | 70 | $18,469 | $8,911 | 48.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 92 | 107 | $9,512 | $3,800 | 39.9% |
About Dr. Pamela Landon, M.D
Dr. Pamela Landon, M.D is a Hematology & Oncology healthcare provider based in Joplin, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1477500700.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Pamela Landon, M.D has received a total of $2,717 in payments from pharmaceutical and medical device companies, with $150.61 received in 2024. These payments were reported across 104 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($2,377).
As a Medicare-enrolled provider, Landon has provided services to 1,576 Medicare beneficiaries, totaling 3,056 services with total Medicare billing of $263,041. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Other Specialties Hematology & Oncology, Hematology & Oncology
- Location Joplin, MO
- Active Since 05/30/2006
- Last Updated 05/28/2025
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1477500700
Products in Payments
- OPDIVO (Biological) $193.95
- KISQALI (Drug) $164.12
- Imbruvica (Drug) $157.85
- BLENREP (Biological) $123.43
- IMBRUVICA (Drug) $118.95
- TAGRISSO (Drug) $111.82
- TEG6s HEMOSTASIS SYSTEM (Device) $108.04
- ZYTIGA (Drug) $107.09
- ZALTRAP (Drug) $99.00
- Neulasta (Biological) $85.32
- Erleada (Drug) $83.81
- Abraxane (Drug) $73.15
- OSTEOCOOL RF ABLATION (Device) $68.68
- Zydelig (Drug) $60.04
- PROVENGE (Drug) $57.86
- Kyprolis (Drug) $55.46
- LUMAKRAS (Drug) $54.43
- Cabometyx (Drug) $53.29
- Rubraca (Drug) $52.59
- Nplate (Biological) $49.63
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Joplin
Dr. Anisa Hassan, M.d, M.D
Hematology & Oncology — Payments: $14,208
Hematology & Oncology $14,208
Matthew Miller, D.o, D.O
Hematology & Oncology — Payments: $7,036
Hematology & Oncology $7,036
Regine Leconte, M.d, M.D
Hematology & Oncology — Payments: $6,937
Hematology & Oncology $6,937
Dr. Kerry Williams-Wuch, M.d, M.D
Hematology & Oncology — Payments: $3,800
Hematology & Oncology $3,800
Samir Dalia, Md, MD
Hematology & Oncology — Payments: $3,276
Hematology & Oncology $3,276
Amir Anis
Hematology & Oncology — Payments: $3,158
Hematology & Oncology $3,158